Baldwin Wealth Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,961
Closed -$273K 238
2024
Q4
$273K Sell
2,961
-5,032
-63% -$484K 0.02% 196
2024
Q3
$742K Buy
+7,993
New +$693K 0.05% 148

Other funds holding LMAT

Baldwin Wealth Partners's LMAT Position: Q1 2025 in Review

Baldwin Wealth Partners sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 2,961 shares — an estimated $273K sold.

Baldwin Wealth Partners first reported a position in LMAT in Q3 2024 and held it in 2 quarters. The position peaked at $742K in Q3 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Baldwin Wealth Partners reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Baldwin Wealth Partners sold 2,961 LeMaitre Vascular shares in Q1 2025, an estimated $273K.
  • Baldwin Wealth Partners first reported a position in LeMaitre Vascular in Q3 2024 and held it in 2 quarters.
  • Baldwin Wealth Partners's LeMaitre Vascular position peaked at $742K in Q3 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Baldwin Wealth Partners's 13F filing for Q1 2025, filed 14 Apr 2025.